Recombinant Human Arginase 1

recombinant human arginase 1 · Bio-Cancer Treatment International Limited

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for Recombinant Human Arginase 1, covering 2017-07-28 to 2017-07-31. Get the full timeline:

Most recent: Clinical Trial Update: A Pilot Study of Recombinant Human Arginase 1 (rhArg1) in Patients With Relapsed or Refractory Leukemia or Lymphoma [Phase 1]

See pricing